BioVie Inc Warrant
BIVIW
8 hedge funds and large institutions have $691K invested in BioVie Inc Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
16% more capital invested
Capital invested by funds: $596K → $691K (+$95.2K)
8.02% more ownership
Funds ownership: 549.28% → 557.3% (+8%)
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAG
Armstrong Advisory Group
Needham,
Massachusetts
|
+$19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
-$5.45K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$1.53K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
-$1.46K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$835 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$115 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DC
1
Diametric Capital
Boston,
Massachusetts
| $233K | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $155K | – | – | – |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $142K | -$1.53K | -5,308 | -1% |
|
|
PCM
4
Prelude Capital Management
New York
| $57.9K | – | – | – |
|
|
MA
5
MYDA Advisors
Woodmere,
New York
| $52.4K | -$1.46K | -5,087 | -3% |
|
|
HCM
6
Heights Capital Management
San Francisco,
California
| $27.9K | – | – | – |
|
|
AAG
7
Armstrong Advisory Group
Needham,
Massachusetts
| $20.4K | +$19K | +65,900 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $3.45K | -$835 | -2,904 | -21% |
|
|
9
Cerity Partners
New York
| – | -$5.45K | -20,112 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$115 | -425 | Closed |
|
BIVIW Hedge Fund Activity: Q1 2026 in Review
8 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in BioVie Inc Warrant (BIVIW) for Q1 2026, worth a combined $691K — up 16% from $596K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIVIW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest buyer was Armstrong Advisory Group, opening a new position worth an estimated $19K. The largest seller was Cerity Partners, exiting entirely with an estimated $5.45K sold.
- 8 institutional investors held BioVie Inc Warrant (BIVIW) as of Q1 2026, down from 9 in Q4 2025.
- Funds reported $691K of BioVie Inc Warrant stock for Q1 2026, up 16% quarter-over-quarter.
- 1 fund opened new BioVie Inc Warrant positions in Q1 2026 and 2 closed out, a net change of -1 holder.
- The largest BioVie Inc Warrant buyer in Q1 2026 was Armstrong Advisory Group, an estimated $19K added.
- The largest BioVie Inc Warrant seller in Q1 2026 was Cerity Partners, an estimated $5.45K sold.
Based on aggregated 13F filings for Q1 2026.